SCHEMBL7016256

SCHEMBL7016256

COc1cccc(Cc2nc3ccccc3c(=O)n2-c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)c1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.64
USP2 O75604 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
MEN1 O00255 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
KMT2A Q03164 1/20 0.51
PDE10A Q9Y233 5/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HTR7 P34969 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7013129 0.90 ALDH1A1 (0.65) ALDH1A1USP2NPSR1NPC1RAB9A
SCHEMBL7014792 0.90 ALDH1A1 (0.74) ALDH1A1NPSR1NPC1RAB9AMEN1
SCHEMBL7020221 0.89 ALDH1A1 (0.63) ALDH1A1USP2NPSR1NPC1RAB9A
SCHEMBL7020310 0.88 ALDH1A1 (0.57) ALDH1A1NPSR1NPC1RAB9AKMT2A
SCHEMBL7023964 0.88 ALDH1A1 (0.65) ALDH1A1NPSR1NPC1RAB9AMEN1
SCHEMBL7023261 0.87 ALDH1A1 (0.70) ALDH1A1NPSR1NPC1RAB9AMEN1
SCHEMBL7021872 0.87 ALDH1A1 (0.58) ALDH1A1NPSR1NPC1RAB9AMEN1
SCHEMBL7020235 0.87 ALDH1A1 (0.58) ALDH1A1NPSR1NPC1RAB9AKMT2A
SCHEMBL7016915 0.86 ALDH1A1 (0.57) ALDH1A1NPSR1NPC1RAB9AKMT2A
SCHEMBL7018437 0.86 ALDH1A1 (0.57) ALDH1A1NPSR1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003106435-A1 FUSED-RING PYRIMIDIN-4(3H)-ONE DERIVATIVES, PROCESSES FOR THE PREPARATION AND USES THEREOF SANKYO COMPANY, LIMITED (JP) 2003-12-24 WO disclosed